223 related articles for article (PubMed ID: 32673169)
21. Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.
Sharafeldin N; Richman J; Bosworth A; Chen Y; Singh P; Patel SK; Wang X; Francisco L; Forman SJ; Wong FL; Bhatia S
J Clin Oncol; 2020 Apr; 38(12):1312-1321. PubMed ID: 32083992
[TBL] [Abstract][Full Text] [Related]
22. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
[TBL] [Abstract][Full Text] [Related]
23. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
24. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
25. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
Beyzadeoglu M; Dirican B; Oysul K; Arpaci F; Pak Y
Haematologia (Budap); 2002; 32(1):25-30. PubMed ID: 12243552
[TBL] [Abstract][Full Text] [Related]
27. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
[TBL] [Abstract][Full Text] [Related]
32. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report.
Johnston EE; Meng Q; Hageman L; Wu J; Ross E; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Armenian SH; Weisdorf DJ; Landier W; Bhatia S
Blood Adv; 2023 Jun; 7(12):2843-2854. PubMed ID: 36724527
[TBL] [Abstract][Full Text] [Related]
33. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
Frisk P; Bratteby LE; Carlson K; Lönnerholm G
Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
[TBL] [Abstract][Full Text] [Related]
34. Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
Wadhwa A; Chen Y; Holmqvist A; Wu J; Ness E; Parman M; Kung M; Hageman L; Francisco L; Braunlin E; Miller W; Lund T; Armenian S; Arora M; Orchard P; Bhatia S
Biol Blood Marrow Transplant; 2019 Feb; 25(2):328-334. PubMed ID: 30292746
[TBL] [Abstract][Full Text] [Related]
35. Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Armenian SH; Arora M
J Clin Oncol; 2022 Jun; 40(18):1991-2003. PubMed ID: 35263165
[TBL] [Abstract][Full Text] [Related]
36. Cataracts after autologous bone marrow transplantation in children.
Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
Acta Paediatr; 2000 Jul; 89(7):814-9. PubMed ID: 10943964
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation.
Latz D; Alfrink M; Nassar N; Beyerle C
Onkologie; 2004 Oct; 27(5):477-9. PubMed ID: 15585979
[TBL] [Abstract][Full Text] [Related]
38. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS report.
Holmqvist AS; Meng Q; Dai C; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas N; Bosworth A; Te HS; Bhatia R; Rosenthal J; Wong FL; Weisdorf D; Armenian SH; Bhatia S
Leukemia; 2024 Mar; 38(3):601-609. PubMed ID: 38374408
[TBL] [Abstract][Full Text] [Related]
39. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
[TBL] [Abstract][Full Text] [Related]
40. Cataract incidence after total-body irradiation.
Zierhut D; Lohr F; Schraube P; Huber P; Wenz F; Haas R; Fehrentz D; Flentje M; Hunstein W; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):131-5. PubMed ID: 10656384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
